Lung cancer involves critical molecular alterations such as DNA damage, epigenetic changes, and mutations in key genes like TP53, KRAS, and EGFR, which activate abnormal signaling pathways that promote tumor growth and metastasis [172,173]. The gene discussed is TP53; the disease is neoplasm.